Well, Pride Month is coming to a close, and so is this column. I wouldn’t be Dr. Lexx if I didn’t leave you with a little bit of education from a sex-positive and shame-free perspective.

Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal second quarter 2025 results through the filing of its Form 10-Q. Since our previous update, the company has made progress with its ...

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs ...

Welcome to Better Sex With Dr. Lexx, a monthly column where sex therapist, educator and consultant Dr. Lexx Brown-James shares expertise, advice and wisdom about sex, relationships and more.

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Get his next trade alert for free, right here. Lexaria Bioscience Corp LEXX shares are trading lower by 6.5% to $2.43 Thursday morning after the company finalized agreements for a registered ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...